The library will operate on a duty schedule between 22 December 2025 and 4 January 2026. During this period, it will be possible to upload publications, but all other services will be suspended.
Q1
Biochemistry, Genetics and Molecular Biology (miscellaneous)
(2024)
Q1
Medicine (miscellaneous)
(2024)
3.
Karetka, A. J.,
Papp, B.,
Lekli, I.,
Vlase, A. M.,
Pallag, A.,
Vicaș, L. G.,
Lestyán, A. M.,
Józsa, L.,
Kósa, D.,
Pető, Á.,
Ujhelyi, Z.,
Nacsa, F.,
Bácskay, I.,
Fehér, P.,
Jurca, T.:
In Vitro and in Vivo Efficacy of Different Ointment Formulations Containing Centaurium erythraea Rafn. Aerial Extract.
Pharmaceuticals. 18 (11), 1-27, (article identifier: 1681), 2025.
Kósa, D.,
Pető, Á.,
Bácskay, I.:
Pharmaceutical aspects of conventional and recent developments for the treatment of metabolic diseases and disorders.
In: Pharmacological Targets in Metabolic Diseases. Ed.: by Marcos Roberto de Oliveira, Elsevier, London, 53-62, 2025. ISBN: 9780443273704
Gavra, D. I.,
Kósa, D.,
Pető, Á.,
Józsa, L.,
Ujhelyi, Z.,
Fehér, P.,
Pallag, A.,
Ghitea, T. C.,
Frǎțilǎ, S.,
Jurca, T.,
Bácskay, I.:
Exploring the Correlation between the PASI and DLQI Scores in Psoriasis Treatment with Topical Ointments Containing Rosa x damascena Mill. Extract.
Pharmaceuticals (Basel). 17 (8), 1092-1105, 2024.
Q2
Biochemistry, Genetics and Molecular Biology (miscellaneous)
Q2
Food Science
Q2
Plant Science
18.
Fehér, P.,
Józsa, L.,
Jurca, T.,
Pallag, A.,
Pető, Á.,
Papp, B.,
Bácskay, I.:
Topical formulations containing Rosa Damascena for the treatment of psoriasis: in vitro/ in vivo assessment.
Maced. Pharm. Bull. 69 (Suppl_1), 7-8, 2023.
Gavra, D. I.,
Endres, L.,
Pető, Á.,
Józsa, L.,
Fehér, P.,
Ujhelyi, Z.,
Pallag, A.,
Marian, E.,
Vicaș, L. G.,
Ghitea, T. C.,
Mureşan, M.,
Bácskay, I.,
Jurca, T.:
In Vitro and Human Pilot Studies of Different Topical Formulations Containing Rosa Species for the Treatment of Psoriasis.
Molecules. 27 (17), 1-24, (article identifier: 5499), 2022.